← Back to contracts

Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional

US National Institutes of Health (NIH) grant open #RFA-HG-24-026
Response due Aug 02, 2026 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is soliciting applications under a limited competition for the BBAER Program (UM1 grant mechanism). The program aims to build partnerships and broaden perspectives to advance research on the Ethical, Legal, and Social Implications (ELSI) of genomics and related fields. Clinical trials are optional under this funding opportunity. This is a federal grant opportunity posted on Grants.gov under RFA-HG-24-026.

What they want

Technical requirements
  • Clinical trial capability optional but must be addressed in application
  • Must align with ELSI research priorities as defined by NIH/NHGRI
  • Cooperative agreement (UM1) mechanism requires substantial NIH involvement and oversight

How they evaluate

Submission: Grants.gov federal grants portal

Risks & flags

  • Limited competition designation restricts the pool of eligible applicants, suggesting potential preference for previously funded or pre-identified institutions
  • UM1 cooperative agreement mechanism implies significant NIH programmatic involvement, which can favor incumbent or well-networked research teams

Market context

inferred from NAICS
R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)
NAICS 541715
US market size
$95B
Typical award
$100K – $50M+
Typical buyers
DoDNSFNIHNASADOE
Commonly required
DCAA-compliant accountingITARCMMC L2
Limited Competition: Building Partnerships…
Due Aug 02
Onboard ↗